| T |
| Tabares AH |
- |
Clinical Audit of Thromboembolism Prophylaxis 3 years after the 6th ACCP Report in a Tertiary Care Hospital in Córdoba, Argentina |
| Tabesch R |
- |
Multicenter Evaluation of BCS® XP A Further Development of the Widespread BCS® Coagulation Analyzer |
| Taborski U |
- |
A Multicenter Controlled Trial of Anticoagulation Patient Self-Management in Germany Using the Protime System |
| Taboureau O |
- |
Activation Hypothesis for Coagulation Factor VIIa |
| Taddei S |
- |
Adrenergic and Cholinergic Regulation of Local t-PA Release in Human Vasculature |
| Tadokoro S |
- |
Enhanced Platelet Aggregation and Thrombogenic Tendency in Adiponectin-Deficient Mice |
| |
- |
Negative Regulation of Platelet Function by a Secreted Cell Repulsive Protein, Semaphorin 3A |
| Tagalakis V |
- |
Thrombophilia Is Not a Risk Factor for Peripheral Intravenous Infusion-Associated Thrombophlebitis |
| Tagariello G |
- |
Gene Mutation and ITT Response in the Italian Cohort of Patients with Haemophilia A |
| Tagliabue L |
- |
Italian Experience in the Assessment of Performance of Clinical Laboratories for DNA Analyses to Detect Three Thrombophilic Mutations |
| Tagliaferri A |
- |
Prophylaxis with Factor VIII Protects Children with Hemophilia a from Inhibitor Development |
| |
- |
Eight Novel Mutations in FXI Gene |
| |
- |
Pharmacokinetics, Efficacy and Safety of Solvent/Detergent (S/D) Treated Plasma in Patients with Rare Inherited Coagulation Disorders (RICDs) |
| Tagliaferri A |
- |
Inherited Bleeding Disorders: The Emilia-Romagna Region Register, 2004 Update |
| Tagzirt M |
- |
Thrombin-Activatable Factor X Re-establishes an Intrinsic Amplification in Tenase-deficient Plasmas |
| Tait RC |
- |
Seven Novel Candidate Mutations in Exon 27 and 28 of von Willebrand Gene in Patients with Type 1, Type 2 M and Unclassified von Willebrand Disease |
| Tait C |
- |
36 Novel Factor VIII Mutations in the Scottish Hemophilia a Population |
| Tait RC |
- |
Clinical and Laboratory Predictors of Recurrent Venous Thrombosis: Interim Results from a Multi-center Prospective Observational Study |
| |
- |
Fibrin D-Dimer, by Three Different Assays, is an Independent Predictor of Future Stroke in Patients With Atrial Fibrillation |
| Tait RC |
- |
Evaluation of dHPLC in the Genetic Analysis of Fibrinogen Disorders |
| Tak PP |
- |
Synovial Microparticles in Arthritic Patients Support Coagulation and Inflammation |
| |
- |
Complement Activation on the Surface of Cell-Derived Microparticles in Rheumatoid Arthritis |
| Takaaki F |
- |
Diabetic Microangiopathy is a Disease of Disturbance of the PDGF-BB/PKC Axis, But Not of Impaired Expression of Angiogenic Factors |
| Takada Y |
- |
Cobra Cardiotoxins, Members of the Ly-6 Protein Family, Specifically Bind to Integrin alphavbeta3 |
| Takada K |
- |
Verotoxin-1 Activation of the c-Yes in Human Monocytes/THP-1 Monocytic Cells Induces Tissue Factor Expression Through Activations of IKKbeta/NF-kappaB/Rel and ERK/Egr-1 Pathways |
| Takagi A |
- |
In vitro Characterization of Two Missense Mutations Associated with Quantitative Protein S Deficiency |
| |
- |
Targeted Disruption of Mouse Ortholog of the Human MYH9 Responsible for Macrothrombocytopenia with Different Organ Involvement: Hematological, Nephrological, and Otological Studies of Heterozygous KO Mice |
| Takahashi S |
- |
Individual Variation of Platelet Functions after in vitro Incubation with Aspirin: Assessment of Aspirin Resistance in Healthy Subjects Using PFA-100® |
| Takahashi H |
- |
Factor V Mutations, Arg2174Leu, a 5-bp Deletion and Val1813Met, Are Associated with Factor V Deficiency and A Bleeding Tendency |
| Takamatsu H |
- |
Pharmacological Properties of YM-254890, a Specific Gaq/11 Inhibitor, on Thrombosis and Neointima Formation in Mice |
| Takani K |
- |
Identification of Heparin-Binding Region of Snake Venom VEGF (VEGF-F) and Its Blocking Effect on VEGF-A165 |
| |
- |
C-terminal Heparin-Binding Peptide of Snake Venom VEGF Specifically Blocks VEGF-stimulated Endothelial Cell Proliferation |
| Takano K |
- |
Phenotype Correction of Hemophilia A Mice with Adeno-associated Virus (AAV) Vectors Carrying the B domain Deleted Canine Factor VIII Gene |
| |
- |
Phenotype Correction of Hemophilia a Mice with Adeno-associated Virus (AAV) Vectors Carrying the B domain Deleted Canine Factor VIII Gene |
| Takasaki J |
- |
Pharmacological Properties of YM-254890, a Specific Gaq/11 Inhibitor, on Thrombosis and Neointima Formation in Mice |
| Takayama M |
- |
Safety for Stroke in Appling Modified Recombinant T-PA, Monteplase, in Patients with Acute Myocardial Infarction in Japanese Real Clinical World |
| Takeda N |
- |
Cardiac Involvement in Pathologic Findings of Factor XIII Knockout Mice |
| |
- |
Circadian Oscillation of Thrombomodulin Gene Expression in Peripheral Tissues |
| Takemura Y |
- |
Analyses of the Interaction of Platelet Collagen Receptor Glycoprotein (GP) VI with Various Types of Collagen |
| Takeoka S |
- |
Hemostatic Effects of Polymerized Albumin Particles Carrying Recombinant Glycoprotein Iba as Platelet Substitutes in vitro and in vivo |
| Takeoka S |
- |
Hemostatic Effects of Polymerized Albumin Particles Carrying Fibrinogen-g Chain Dodecapeptide as Platelet Substitutes in vitro and in vivo |
| Takeshi N |
- |
Diagnosis of Deep Vein Thrombosis by Soluble Fibrin or D-dimer |
| Takeyama M |
- |
Factor VIII Mimetic Antibody: (2) In Vitro Assessment of Cofactor Activity in Hemophilia A |
| Taki M |
- |
Retrospective Study on Thrombosis in Japanese Children |
| Taki M |
- |
Six years' Experience of Regular Continuous Prophylactic Infusion of Clotting Factor Concentrates in Infants and Young Children with Severe Hemophilia A and B in Japan |
| Takizawa H |
- |
Highly Potent Anti-human GPVI Monoclonal Antibodies Derived from GPVI Knockout Mouse Immunization |
| Talaulikar D |
- |
Case Series of Acquired Factor VIII Inhibitors: Profile in the Australian Capital Territory and Review of Literature |
| Taliani MR |
- |
Prevalence of Thrombophilic Abnormalities in Patients with Deep Vein Thrombosis or Pulmonary Embolism |
| Taliani MR |
- |
Duration of Anticoagulant Treatment and Recurrence of Venous Thromboembolism in Patients with and without Thrombophilia |
| |
- |
High Incidence of Bilateral Deep Vein Thrombosis in Cancer Patients |
| Tambunan KL |
- |
The Relationship Between Hypercoagulable State and Sudden Sensory Neural Deafness |
| |
- |
The Rise of Plasminogen Activator Inhibitor-1 Activity in Coronary Artery Bypass Grafting of Type 2 Diabetes Patients |
| Tamimoto S |
- |
A Novel Molecular Marker of Soluble Fibrin Monomer-Fibrinogen Complex Is Quite Valuable for Diffrential Diagnosis of Septic Pneumonia and Simple Pneumonia |
| |
- |
Clinical Importance of Measurement of Soluble Fibrin Monomer-Fibrinogen Complex in Patients with Disseminated Intravascular Coagulation Syndrome and Hypercoagulable State |
| Tammik O |
- |
Tissue Factor Regulation, RhoA Localization, and Induction of Apoptosis in Human Cancer Cell Lines upon Simvastatin Treatment |
| Tammiste I |
- |
A Heterodimeric Metalloprotease from Vipera Lebetina Venom Induces Human Endothelial Cell Apoptosis |
| Tamosiuniene R |
- |
Aggravation of Quality of Life for Patients with Ischaemic Heart Disease and Chronic Atrial Fibrillation on Oral Anticoagulation Therapy: Experience in Lithuania |
| Tamsma JT |
- |
Clearance of Plasminogen Activator Inhibitor-1 in Low-Density Lipoprotein Receptor-Related Protein Deficient Mice |
| Tamura S |
- |
Adenovirus-Mediated Transfer of Human Placental Ecto-Nucleoside Triphosphate Diphosphohydrolase to Vascular Smooth Muscle Cells Suppresses Platelet Aggregation in vitro and Arterial Thrombus Formation in vivo |
| Tamura N |
- |
Role of Thrombin Formed on the Surface of Activated Platelets on the Three-Dimensional Growth of Platelet Thrombi Formed on the Collagen Fibrils under Blood Flow Conditions |
| Tamura N |
- |
R-138727, the Active Metabolite of Prasugrel (CS-747, LY640315), Inhibits Platelet Aggregation and Thrombus Formation under Blood Flow Conditions |
| Tamura N |
- |
Antithrombotic Mechanisms Achieved by Selective Extraction of Cholesterol from Platelet Membrane by Methyl-b-Cyclodextrin |
| Tan KT |
- |
Soluble CD40L in Peripheral Artery Disease: Relationship with Disease Severity, Platelet Markers and the Effects of Angioplasty |
| Tan ZH |
- |
Treatment with Gelatin Absorbed Clodronate in the Management of Immune Thrombocytopenic Purpura in a Rat Model |
| Tan T |
- |
ZPI Gene Mutations and Myocardial Infarction |
| Tanabe H |
- |
Standardization of Assays for Plasma Fibrin-Fibrinogen Degradation Products |
| Tanaka H |
- |
Development of a Latex Agglutination Test for the Measurement of Elastase-Digests of Fibrin in Plasma and Its Application to Clinical Samples |
| Tanaka A |
- |
Elevated Platelet Delivered Microparticles and Lesion Morphology in Acute Coronary Syndrome |
| Tanaka S |
- |
Evaluation of Shape Change in Chilled Blood Platelet Using Light Scattering |
| Tanaka I |
- |
Factor VIII Mimetic Antibody: (2) In Vitro Assessment of Cofactor Activity in Hemophilia A |
| Tanaka A |
- |
Factor V Mutations, Arg2174Leu, a 5-bp Deletion and Val1813Met, Are Associated with Factor V Deficiency and A Bleeding Tendency |
| Tanaka T |
- |
Age-Related Effects of Regular Physical Activity on Coagulation Factors in Men |
| Tanaka H |
- |
Degradation of Cross-linked Fibrin by Plasmin Together with Granulocyte-elastase under Certain Clinical Conditions |
| Tanaka N |
- |
Inhibition of 5-Hydroxytriptamine2A (5-HT2A) Receptor Prevents Occlusive Thrombus Formation on Neointima of Rabbit Femoral Artery |
| Tanaka S |
- |
Platelet Thrombus Formation in Blood Vessel-Mimicking Microchannel |
| Tanashian M |
- |
Haemorheology and Haemostasis in Ischemic Cerebrovascular Diseases |
| Tanashian M |
- |
The Evaluation of Disfunction of Endothelium in Patients with Atherosclerosis of Carotid System and Reversible Neurological Deficit |
| |
- |
Hemorheology, Hemostasis and Antiaggregate Activity of Endothelium in Patients with Hypertensive Small Deep Infarcts |
| |
- |
Hemorheology, Hemostasis in Patients with Arterial Hypertension |
| Tanck MWT |
- |
Defining Subclinical Phenotypes for Venous Thromboembolism through Measurement of a Hypercoagulable State in Thrombophilic Families |
| Tandon NN |
- |
GPVI-Deficient Mice Lack Collagen Responses and are Protected Against Experimentally-Induced Pulmonary Thromboembolism |
| Tandon NN |
- |
Highly Potent Anti-human GPVI Monoclonal Antibodies Derived from GPVI Knockout Mouse Immunization |
| Tang S-W |
- |
Derivatives of Coenzyme A Inhibit Platelet Aggregation via Effects at P2Y1 and P2Y12 Receptors |
| Tang J |
- |
Macrophage Expression of Active MMP-9 Is Sufficient to Induce Plaque Rupture in ApoE/ Mice |
| Tanganelli P |
- |
N-3 Polyunsaturated Fatty Acids Selectively Affect Circulating Microparticle Subpopulations in Patients with Myocardial Infarction |
| Tani T |
- |
Protective Effect of Endothelial Injury Administrated by Antithrombin Concentrates and Neutrophil Elastase Inhibitor in Endotoxin-Treated Rat |
| |
- |
Expression of Plasminogen Activator Inhibitor-1 and Bax in Porcine Liver Transplantation Protective Effect of Tauroursodeoxycholic Acid to Apoptosis |
| Tani Y |
- |
Platelet Thrombus Formation in Blood Vessel-Mimicking Microchannel |
| Tani Y |
- |
Evaluation of Shape Change in Chilled Blood Platelet Using Light Scattering |
| Taniguchi M |
- |
Pharmacological Properties of YM-254890, a Specific Gaq/11 Inhibitor, on Thrombosis and Neointima Formation in Mice |
| |
- |
Prevention of Postoperative Pulmonary Embolism in the Japanese Academic Medical Center |
| Tanii M |
- |
Paracrine Loop between VEGF-C/Flt-4 and PDGF-BB/PDGFR-Beta Systems Contributes Therapeutic Angiogenesis Using FGF-2 Gene Transfer in Ischemic Hind Limbs |
| Tanne D |
- |
Aspirin Resistance in Acute Brain Ischemia: Association with Stroke Severity and Outcome |
| Tanne D |
- |
Low rate of Responsiveness to Aspirin in Acute Brain Ischemia: Association with Stroke Severity and Clinical Outcome |
| Tannert-Otto S |
- |
Extracellular RNA Potentiates Factor VII Activating Protease (FSAP)Mediated Inhibition of Vascular Smooth Muscle Cell Proliferation Induced by Platelet-Derived Growth Factor-BB (PDGF-BB) |
| Tanoue K |
- |
Aspirin-Resistant Thromboxane Biosynthesis in Patients with Coronary Artery Disease; Role of Systemic Inflammation and Glycemic Control |
| |
- |
Advanced Glycation End Products Upregulate Endothelial COX-2 Expression and Induce Aspirin Resistant Thromboxane Synthesis by Platelets |
| Tans G |
- |
Effect of Oral Contraceptives on the Anticoagulant Activity of Protein S in Plasma |
| |
- |
Thrombin Generation and Activated Protein C Resistance in Factor V Leiden Pseudo-homozygous Patients |
| Tantry U |
- |
High Dose Clopidogrel and Eptifibatide: The Optimum Strategy to Prevent Myocardial Necrosis in Elective Stenting? Results from the CLEAR PLATELET Study |
| |
- |
Thromboelastography Is a Useful Predictor of Stent Thrombosis |
| |
- |
Hypercoagulability Measured By TEG Strongly Predicts Recurrent Ischemic Stents Post Coronary Stenting |
| Tantry U |
- |
Over Estimation of Aspirin Resistance: 1 Out of 143 Patients Exhibiting True Aspirin Resistance |
| Tantry U |
- |
The Relation of Dosing to Clopidogrel Responsiveness and the Incidence of High Post-Treatment Platelet Aggregation in Patients Undergoing Coronary Stenting |
| |
- |
Viral Respiratory Tract Infections Increase Platelet Reactivity and Activation an Explanation for Higher Rates of MyocardialInfarction and Stroke during Viral Illness |
| |
- |
Clopidogrel Effect on Platelet Reactivity in Patients with Stent Thrombosis: Results of the CREST Study |
| Tapon-Bretaudière J |
- |
Factor X Gene Mutations Affecting the Gla Domain of the Protein |
| Tappenden KA |
- |
Evaluation of Fluorogenic Substrates for the Monitoring of Thrombin Generation |
| |
- |
The Effect of Corn Trypsin Inhibitor on Whole Blood Thrombin and Thrombus Generation Parameters |
| Tappenden KA |
- |
Whole Blood and Plasma Thrombus Generation Derived from Thromboelastography as an Alternative to Endogenous Thrombin Potential |
| Tappenden K |
- |
Thrombin Activatable Fibrinolysis Inhibitor (TAFI) has Different Effects on Fibrinolysis Induced by Tissue-Type Plasminogen Activator (t-PA) and Urokinase-Type Plasminogen Activator (u-PA) in a Whole Blood Thromboelastography Model |
| Tapson VF |
- |
Does Body Weight Influence Physician Practices for Providing Venous Thromboembolism Prophylaxis to Acutely Ill Medical Patients? Findings from IMPROVE |
| |
- |
Physician Practices for Providing Venous Thromboembolism Prophylaxis to Hospitalized Acutely Ill Medical Patients: Findings from the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) |
| |
- |
Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients in Intensive Care Units |
| Tapson VF |
- |
The Influence of Previous or Currently Active Cancer on Venous Thromboembolism Prophylaxis Prescribing Practices in Acutely Ill Medical Patients |
| Taraborelli T |
- |
Insulin Resistance and Platelet Activation in Obese Women |
| Tarantino M |
- |
Clinical Efficacy and Safety Evaluation of ADVATE Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method (rAHF-PFM) During Surgical and Invasive Procedures |
| Tarantino MD |
- |
Pilot Dose Finding and Pharmacokinetic Study of Bivalirudin in Infants with Thrombosis |
| Tarantino MD |
- |
The Incidence and Outcome of Intracranial Hemorrhage in Newborns with Hemophilia: Analysis of the Nationwide Inpatient Sample (NIS) Database |
| |
- |
FCGR3A Genotype Affects the Platelet Response to Immune Globulin (Ig) Treatment of Acute Immune Thrombocytopenic Purpura (ITP) in Children |
| Taraskina A |
- |
ABCA1 Transporter and Paraoxonase Gene Polymorphisms in Myocardial Infarction and Stroke |
| Taratuta T |
- |
Hyperhomocysteinemia Relapsing after Vitaminous Treatment: Relationship Between C677T Methylenetetrahydrofolatereductase (MTHFR) Genotype and Basal Homocysteine Level |
| Tardy B |
- |
Confirmation of the Pathogenic Role of Ig M and Ig A Anti Heparin-PF4 Antibodies in Patients with Heparin-Induced-Thrombocytopenia |
| Tardy B |
- |
Predictive Factors of Failure of Lepirudine in the Treatment of Heparin-Induced Thrombocytopenia: A French-speaking Collaborative Study (GEHT) |
| Tardy-Poncet B |
- |
Confirmation of the Pathogenic Role of Ig M and Ig A Anti Heparin-PF4 Antibodies in Patients with Heparin-Induced-Thrombocytopenia |
| Tarin F |
- |
Clinical Course and Management of 7 Patients with Congenital Factor XIII Deficiency. Experience of a Single Institution |
| Tariq M |
- |
Role of Periodontal Pathogens in Coronary Artery Disease in Saudis |
| Tarsia P |
- |
The Heparins and Cancer: Review of Clinical Trials and Biological Properties |
| Tarumi T |
- |
Factor VII Arg277His Mutation Induced Discrepancy of Factor VII Activity Levels Using Tissue Factor from Different Sources |
| Tas P |
- |
Rosuvastatin Reduces Platelet Activation in Heart Failure: Role of Nitric Oxide Bioavailability |
| Tashiro H |
- |
Increased Levels of Hepatocyte Growth Factor in Patients with DIC |
| Tasker AJ |
- |
Fatal Pulmonary Embolism and Cancer. A Study of 21 500 Post-Mortems over 35 years |
| Tassanee P |
- |
Vitamin K Status in Mothers and Their Newborn Babies: Role of Dietary Phylloquinone Intake |
| Tatsanavivat P |
- |
Changes in Thrombogenic Markers but not Factor XIII in Left Atrium of Thai Patients with Mitral Stenosis |
| Tatsumi K |
- |
Stellate Cells Produce ADAMTS13 in Human Liver |
| Tavares J |
- |
A Novel P-Selectin Inhibitor, PSI-697, Demonstrates Positive Activity Following Oral Administration in Rodent Models of Vascular Inflammation |
| Tavares A |
- |
The Spectrum of Mutations and Molecular Pathogenesis of Haemophilia A in 163 Portuguese Patients |
| Tavares ER |
- |
Intraoperative Automatic Autotransfusion for Lung Transplantation |
| Tavella MH |
- |
Identification of Gene Defects in Brazilian Patients with Types 2B, 2M and 3 of von Willebrand Disease |
| |
- |
Retrospective and Prospective Analysis of the Incidence of Venous Thromboembolism in First-Degree Relatives of Factor V Leiden and Factor II G20210A Carriers |
| Tayebjee MH |
- |
Soluble CD40L in Peripheral Artery Disease: Relationship with Disease Severity, Platelet Markers and the Effects of Angioplasty |
| Taylor J |
- |
Effect on the Tissue Factor Pathway of Cessation of Warfarin Anticoagulant Therapy |
| Taylor JM |
- |
Heparin Selectively Inhibits CD11b High Affinity Neo-epitope Expression in vivo During Coronary Artery Bypass Surgery |
| Taylor F |
- |
Early Control of the First Stage of the Baboon Response to LD100 E. Coli Optimizes the Efficacy and Demonstrates an Antiinflammatory Effect of APC |
| Taylor M |
- |
Improved Oral Anticoagulant Therapy Monitoring by Eliminating ISI and MNPT from INR Determinations |
| Taylor V |
- |
Development and Evaluation of an Automated Immunoassay for the Determination of D-Dimer on the Abbott AxSYM® Analyzer |
| Taylor J |
- |
Influence of the Tissue Factor Pathway on Initiation of Warfarin Anticoagulant Therapy |
| Taylor M |
- |
Preliminary Results of a Cross-Sectional Study of Mild Hemophilia A in Newfoundland and Labrador, Canada |
| Taylor E |
- |
Effective Venous Thromboembolic Risk Assessment in Pregnancy Allows Appropriate Thromboprophylaxis: a Prospective Outcomes Study |
| Tcherkasova K |
- |
Effect of Stress on Total Plasma Homocystein Concentration in Rats |
| te Velthuis H |
- |
Serum Levels of Soluble Tissue Factor and the Risk of Future Coronary Artery Disease; The EPIC-Norfolk Prospective Population Study |
| Teece S |
- |
Retrospective Calculation of the Modified Wells' Clinical Probability of Pulmonary Embolism: Agreement with Prospective Scoring |
| Teitel JM |
- |
The Generation of Thrombin by High Dose Recombinant Factor VIIa Can Be Mimicked by Lower Factor VIIa Concentrations Combined with Tissue Factor |
| Teixeira GS |
- |
Impact of the First Trimester of Hormone Replacement Therapy on the Levels of Hypercoagulability Markers |
| Telen MJ |
- |
Is the Novel Genetic Mutation, Prothrombin C20209T, an Independent Risk Factor for Stroke among African-Americans with Sickle Cell Anemia? |
| Tellier L |
- |
Microparticles from Smooth Muscle Cells Induce Endothelial Dysfunction, a Phenomenon Prevented by Glycoprotein IIb/IIIa Antagonists |
| Tellier Z |
- |
Pharmacokinetic Study of the Co-administration of a Von Willebrand Factor (VWF) Product Containing Low FVIII Level (WILFACTIN) with a Factor VIII Product |
| |
- |
WILFACTIN: Efficacy and Safety Evaluation of WILFACTIN (a Triple Secured Von Willebrand Factor Product with a Low Factor VIII Content) in Women with Severe Von Willebrand Disease during Gynaecological/Obstetrical Events |
| |
- |
Bilateral Ankle Prosthesis in a Severe Von Willebrand Disease Patient under Substitutive Wilfactin Treatment |
| |
- |
Immune Tolerance Induction with Highly Purified Plasma-Derived Factor VIII Containing Von Willebrand Factor in Hemophilia a Patients with High-Responding Inhibitors |
| |
- |
Evolution of Antithrombin (AT) and Fibrinogen (Fg) Levels during Induction Chemotherapy with L-asparaginase (Asp) in Adult Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL). Clinical Outcomes and Use of Coagulation Supportive Treatments: The CAPELAL Study |
| Tellini I |
- |
Protein Z Decreases During Follow-up of Patients with Acute Coronary Syndromes |
| |
- |
Clotting Profile by Sonoclot Analysis Is Different in Patients Undergoing Off-Pump and On-Pump Coronary-Artery Bypass Surgery |
| |
- |
Antiaggreganting Agents Do Not Influence the Sonoclot Profile |
| ten Berge IJM |
- |
Laboratory Markers of Cardiovascular Disease in Systemic Lupus Erythematosus: Evidence of a Latent Hypercoagulable State |
| ten Cate H |
- |
Laboratory Markers of Cardiovascular Disease in Systemic Lupus Erythematosus: Evidence of a Latent Hypercoagulable State |
| |
- |
Low Molecular Weight Heparin Attenuates Multiorgan Failure in DIC |
| |
- |
Activation of the Contact Factor System and Its Predictive Role in Coronary Heart Disease and Ischemic Stroke; Follow Up from the Second Northwick Park Heart Study |
| Ten Cate H |
- |
Pravastatin Reduces Levels of the Glycoprotein IIIa Subunit from the Fibrinogen Receptor on Platelet-Derived Microparticles in Patients with Type 2 Diabetes |
| |
- |
Diabetes Mellitus Does Not Increase Thrombogenicity of the Arterial Vessel Wall in Atherosclerotic LDLr-/- Mice |
| ten Cate H |
- |
A Hypercoagulable State in Myeloperoxidase Deficient Mice |
| |
- |
ASIS Blocks Tissue Factor Activity in the Heart after Ischemia/Reperfusion Injury in Mice |
| |
- |
Plasminogen Activator Inhibitor-1 Plasma Levels Increase after Myocardial Ischemia/Reperfusion Injury in Mice |
| |
- |
Soluble Tissue Factor: A Marker of Microvascular Disease in Patients with Type 2 Diabetes |
| Ten Cate H |
- |
Activity and Localization of Tissue Factor and Factor VII in Organs of Normal and Endotoxemic Mice |
| ten Cate H |
- |
Analysis of Blood Coagulation in Mice: Pre-analytical Conditions and Comparison of a Home-made Assay for Thrombin-antithrombin Complexes with Two Commercial Assays |
| |
- |
Impaired Thrombus Formation after Sterile Inflammation Induced by Endotoxin in a Murine Carotid Artery Thrombosis Model |
| |
- |
Changes in Fibrinolysis Activity after Angiotensin II Receptor Blockade in Patients Undergoing Renal Artery Angiography |
| |
- |
Plasma Levels of PAI-1 and Risk of Death from Dengue: No Association with the 4G/5G Promoter Polymorphism |
| ten Cate-Hoek AJ |
- |
Management Studies Using a Combination of D-Dimer Test Result and Clinical Probability to Rule Out Venous Thromboembolism; A Systematic Review |
| Ten Kate MK |
- |
Absolute Risk of Venous Thromboembolism (VTE) Associated with Nephrotic Syndrome. Results from the Coltrane Study |
| |
- |
A Prospective Study to Assess the Absolute Incidence of Venous Thromboembolism (VTE) Associated with Hereditary Deficiencies of Protein C, Protein S and Antithrombin and the Contribution of Cosegregation of Other Thrombophilic Defects |
| |
- |
Absolute Risk of Arterial Thromboembolism (ATE) Associated with Nephrotic Syndrome. Results from the Coltrane Study |
| Ten Kate MK |
- |
Protein C/S Ratio to Identify Protein S Type I Non-Deficient Relatives at High Risk of Venous Thromboembolism (VTE). Results from a Family Cohort Study (DESCARTES) |
| |
- |
Effects of Highly Active Antiretroviral Therapy on the Risk of Venous and Arterial Thromboembolism in Male and Female HIV Positive Patients |
| |
- |
Protein C/S Ratio Improves Accuracy to Identify Hereditary Protein S Deficiency Type I. Results from a Family Cohort Study (DESCARTES) |
| Ten Kate MK |
- |
Risk of Recurrent Venous Thromboembolism (VTE) Associated with Hereditary Deficiencies of Protein C, Protein S and Antithrombin Depends on Cosegregation with Other Thrombophilic Disorders: A Prospective Family Cohort Study |
| |
- |
Hereditary Deficiencies of Protein C, Protein S or Antithrombin Are No Risk Factors for Arterial Thromboembolism (ATE). Results from a Large Family-Cohort Study (DESCARTES) |
| |
- |
Hereditary Deficiencies of Protein C, Protein S And Antithrombin Protect Against Bleeding During Anticoagulant Treatment. Results from a Family Cohort Study (DESCARTES) |
| |
- |
Absolute Risk of Venous Thromboembolism (VTE) Associated with Hereditary Deficiencies of Protein C, Protein S or Antithrombin Strongly Depends on Cosegregation of other Thrombophilic Disorders. A Retrospective Family Cohort Study (DESCARTES) |
| ten Wolde M |
- |
Clinical Usefulness of Prothrombin Fragment 1+2 in Patients with Suspected Pulmonary Embolism |
| |
- |
Brain Natriuretic Peptide in Hemodynamically Stable Acute Pulmonary Embolism |
| Tenchini ML |
- |
Type II Mutation (Glu117stop) Causes Factor XI Deficiency by Inducing Allele Specific mRNA Degradation |
| |
- |
In-vitro Expression and Functional Characterization of Four Mutations Causing Factor XI Deficiency |
| Tenenbaum G |
- |
Endothelial Protein C Receptor (EPCR) Gene Polymorphisms and sEPCR Levels in Women with Recurrent Pregnancy Loss |
| Teng CM |
- |
Effect of YC-1, a cGMP-dependent Manner, on Heterotypic CellCell Interaction: The Study on Neutrophil-platelet Adhesion |
| Tengborn L |
- |
The EACH Registry: A Prospective European Registry of Acquired Haemophilia (AH) |
| Tenno T |
- |
Tissue Factor Regulation, RhoA Localization, and Induction of Apoptosis in Human Cancer Cell Lines upon Simvastatin Treatment |
| |
- |
The Impact of Tissue Factor Single Nucleotide Polymorphisms on Risk, Outcome and Plasma levels in Acute Coronary Syndrome |
| Tentsova IA |
- |
Using of PCR and RHA Tests for Detection of Hepatitis C Virus Antigen |
| Tenuti I |
- |
Factor VIII:c Levels in Subjects with the Factor V R2Ppolymorphism |
| |
- |
Polymorphisms in the Hemostatic Pathway Genes and the Risk of Myocardial infarction in Patients with Advanced Coronary Artery Disease. Results from the Verona Heart Project |
| Tepljakov A |
- |
Activation of Fibrinolysis System at the Main Arterial and Venous Vessels Thrombosis with the Treatment of Gene-Engineering Thrombolythic Drug Triasa |
| Teplyakov AI |
- |
Endothelial Dysfunction and Atherogenesis Are Induced by Chronic Carbon Disulfide (CS2) Exposure |
| Teplyakov A |
- |
Haemostasis System State, Cytokines, Soluble Cell Adhesion Molecules in Atherosclerosis due to Low-Level Ecological and Professional Irradiation |
| Teplyakova DV |
- |
Endothelial Dysfunction and Atherogenesis Are Induced by Chronic Carbon Disulfide (CS2) Exposure |
| ter Horst SA |
- |
Thrombin-Activatable Fibrinolysis Inhibitor Deficiency Influences the Inflammatory But Not the Procoagulant/Fibrinolytic Response to Escherichia coli-Induced Abdominal Sepsis in Mice |
| Terada C |
- |
Platelet Thrombus Formation in Blood Vessel-Mimicking Microchannel |
| Terada Y |
- |
Protective Effect of Endothelial Injury Administrated by Antithrombin Concentrates and Neutrophil Elastase Inhibitor in Endotoxin-Treated Rat |
| Terada C |
- |
Evaluation of Shape Change in Chilled Blood Platelet Using Light Scattering |
| Teresa P |
- |
Selective Thrombosis of Tumor Vasculature by RGD-directed Delivery of Truncated Tissue Factor (tTF) |
| Terlecki P |
- |
Fibrinolytic Activity in the Patients with Buerger's Disease and PAOD |
| |
- |
The Use of Recombinant Activated Factor VII to Control Postoperative Bleeding in Patients Undergoing Abdominal Aortic Aneurysm Reconstruction |
| Terpilowski T |
- |
von Willebrand Factor and Thrombomodulin in Patients with Thromboangiitis Obliterans |
| Terrisse AD |
- |
Microparticles from Smooth Muscle Cells Induce Endothelial Dysfunction, a Phenomenon Prevented by Glycoprotein IIb/IIIa Antagonists |
| Teruko S |
- |
Fatal Hemorrhagic Disorder and Vascular Intimal Carcinomatosis in Annexin II Expressing Transitional Cell Carcinoma |
| Tesoro S |
- |
Coagulation Screening for Otorhinolaryngoiatric Surgery: A Pharmacoeconomic Appraisal in the Setting of the Italian National Health System |
| Testa S |
- |
The D-dimer (DD) Test to Establish the Duration of Anticoagulation after a First Unprovoked Episode of Venous Thromboembolism (VTE); the Prospective Randomized Prolong Study on behalf of the Italian Federation of Anticoagulation Clinics (FCSA) |
| Testa S |
- |
A Telemedicine Project for Managing Patients on Oral Anticoagulant Therapy |
| Teti G |
- |
Protective Effect of Human Plasma-Derived Protein C in Septic Neonatal Mice |
| Tetsu S |
- |
Biological Properties of a Specific Gaq/11 Inhibitor, YM-254890, on Platelet Functions and Thrombus Formation under High-shear Stress |
| Tezol A |
- |
Factor V Leiden and Prothrombin G20210A Mutations in Children with Cerebral Palsy |
| Thaisrivongs DA |
- |
Localization of Factor Va and Factor Xa Binding to Lipid Rafts in Human Platelets |
| Thalamas C |
- |
Long-Haul Flights Do Not Activate Haemostasis in Young Healthy Men |
| Thaler CJ |
- |
Safety and Efficacy of Low-Molecular-Weight Heparin (Dalteparin) in Pregnant Women at Increased Risk of Venous Thromboembolism: A Prospective Stratified Multicentre Trial |
| Than J |
- |
Tissue Factor Pathway Inhibitor (TFPI) during Cardiopulmonary Bypass (CPB) in Children |
| |
- |
Monitoring Haemostasis in Cardiopulmonary Bypass in Children Measures of Heparin Activity |
| |
- |
Platelet Changes during Cardiopulmonary Bypass in Children |
| Tharra K |
- |
Influence of Gender, Age, and Oral Contraception on Hemostatic Parameters Determined by Rotation Thrombelastography |
| Tharratt S |
- |
Low Dose (<60 mcg/kg) Recombinant Factor VIIa in Trauma or Coagulopathy |
| Thati M |
- |
Hyperglycemia Induces Loss of the Protective Endothelial Thrombomodulin Protein C System |
| Thatipelli MR |
- |
Mesenteric Vein Thrombosis: the Etiologic Spectrum of a Unique Thrombotic Disorder |
| |
- |
Natural History of Mesenteric Vein Thrombosis: Incidence of Recurrent Venous Thromboembolism and Survival |
| |
- |
Post-splenectomy Mesenteric Vein Thrombosis: A Critical Analysis of Thrombocytosis as a Risk Factor |
| the AIDA Investigators |
- |
Long-Term Outcomes after Deep-Vein Thrombosis in Asia. The AIDA-Extension Study |
| the ARTEMIS Investigators |
- |
Thromboprophylaxis with Fondaparinux in Acutely Ill Medical Patients Aged 75 years or More, or with Moderate Renal Impairment |
| the PROVE Investigators |
- |
A Comparison of Patients with DVT in Asia and Europe/Australia: Findings from the PROVE Registry |
| the RIETE investigators |
- |
Predictive Factors for Fatal Pulmonary Embolism in 9902 Patients Presenting with an Episode of Venous Thromboembolism. Findings from the RIETE Registry |
| Theakston E |
- |
The D-Dimer Concentration Increases with Age Causing a Marked Effect on the Assay Specificity: Is the D-Dimer Assay Useful As an Exclusion Test in the Elderly? |
| Thedieck S |
- |
Elevated Alpha 1-Antitrypsin Is a Risk Factor for Arterial Ischemic Stroke in Childhood |
| Thelwell C |
- |
Use Of Fluorescent Protein Fusions of Tissue Plasminogen Activator as a Tool for Investigating Fibrinolysis In Vitro |
| |
- |
Is the Conversion of Single-chain to Two-chain Tissue Plasminogen Activator Part of a Deactivation Pathway Rather than Enzyme Activation |
| Theodoridis T |
- |
How Strong Is the Presence of Both Prothrombin and MTHFR Mutation as a Causative Factor of Arterial Thrombosis in Healthy Young Individuals? |
| Theodosiadis G |
- |
References Values of roTEM Instrument |
| |
- |
Mutations Causing Type 3 Von Willebrand Disease in a Small Cohort of Greek Patients |
| Theophilus BDM |
- |
41 Novel Factor VIII Mutations Identified in Haemophilia A Families from the UK Midlands Region |
| Thiele T |
- |
Proteomics as a Tool for Assessment of Therapeutics in Transfusion Medicine: Evaluation of Prothrombin Complex Concentrates |
| Thiene G |
- |
Long-Term Treatment with High-Dose Recombinant Human Antithrombin does not Prevent Acute Humoral Rejection in Primate Recipients of Porcine Xenografts |
| Thienelt CD |
- |
Routine Use of Oral Vitamin K for the Reversal of Anticoagulation with Warfarin in Patients Scheduled for Elective Procedures |
| Thierry VD |
- |
Neonatal Gene Therapy with Lentiviral Vector in Murine Hemophilia a Results in Successful Immune Tolerance Induction to Canine Factor VIII |
| Thiruchelvam A |
- |
Prevalence of Acquired Haemophilia A in the Malaysian Population |
| Thivolet-Bejui F |
- |
MIP-1b and VE-Cadherin Are Implicated in Acute Rejection in Human Heart Transplantation |
| Thom K |
- |
No Major Impact of Prothrombotic Conditions on The Risk of Central Venous Line-Related Thrombotic Events in Children |
| Thom J |
- |
Enhanced Antiplatelet Effect of Clopidogrel in Patients with Aspirin Resistance: A Randomized Crossover Trial |
| Thom K |
- |
Diagnosis of Central Venous Line-Related Thrombotic Events in the Upper Venous System in Children: Combination of Venography, Venous Ultrasound, and Echocardiography |
| Thom J |
- |
Protein Z Gene Polymorphisms, Protein Z Concentration and Ischaemic Stroke |
| |
- |
Platelet Activation in Whole Blood, Red Cell Concentrates and Whole Blood Derived Platelet Concentrates |
| Thomas Z |
- |
Therapy of Isolated Calf Muscle Vein Thrombosis with Low-Molecular-Weight Heparin: Prospective Randomized Study |
| Thomas S |
- |
Conversion of Platelets from a Pro-Aggregatory to Pro-Inflammatory Adhesive Phenotype: A Role for PAF in Spatial Neutrophil Activation on Thrombi |
| Thomas B |
- |
Pro-Fibrinolytic Monoclonal Antibodies That Convert a2-Antiplasmin from a Plasmin Inhibitor to a Substrate |
| Thomas M |
- |
Effect of TGN 255, a Novel Intravenous Direct Thrombin Inhibitor, on the Prolongation of ACT in Patients Undergoing Haemodialysis |
| Thomas A |
- |
36 Novel Factor VIII Mutations in the Scottish Hemophilia a Population |
| Thomas L |
- |
a2-Antiplasmin Interaction with Endothelial Cells Via Integrins |
| Thomas A |
- |
A UK Survey of Prophylaxis in Paediatric Patients with Haemophilia |
| Thomas V |
- |
Modulation of Platelet Adhesion by Antithrombin |
| |
- |
The 807C/T Polymorphism in the a-Subunit of Integrin a2b1 Modulates Platelet Adhesion onto Immobilized Collagen Under Arterial Flow Conditions |
| Thomas A |
- |
Early FVIII Exposure and Subsequent Inhibitor Development in Children with Severe Haemophilia A |
| Thomas S |
- |
Thrombin Generation under Flow Conditions in the Presence of Direct and Indirect Inhibitors of Factor Xa |
| Thomas L |
- |
Regulation of Model Thrombus Lysis by TAFIa, PAI-1 and a2-Antiplasmin |
| Thomassen S |
- |
Laboratory Markers of Cardiovascular Disease in Systemic Lupus Erythematosus: Evidence of a Latent Hypercoagulable State |
| Thomassen LGD |
- |
Effect of Oral Contraceptives on the Anticoagulant Activity of Protein S in Plasma |
| Thomassen MCLGD |
- |
Disclosure of Microdomain Structure and Function in Arterial Thrombi of Heterogeneous Composition |
| Thompson AR |
- |
ELISA for Detecting Immune Responses to Factor VIII |
| |
- |
Immunomodulation of Transgene Responses Following Naked DNA Transfer of FVIII into Hemophilia A Mice |
| |
- |
Severe Hemophilia B Due to a 6 kb Deletion Including Exon 4, Due to Non-Homologous Recombination and Associated with Dysfunctional Protein Missing the First EGF-like Domain |
| Thompson J |
- |
Increased Levels of Procoagulant Factors Associated with Increased Potential for Thrombin Generation in Patients with Premature Myocardial Infarction |
| Thompson AR |
- |
Mapping of B Cell Epitopes on the Factor VIII C2 Domain |
| Thong B |
- |
Analysis of Plasma Proteins Bound to Catheter Surfaces |
| Thorgrimsson J |
- |
Utility and Multi-site Acceptance of Patient Self-Reporting of INR Self-Test Results to a Central Database Utilizing a Computerized Interactive Voice Response System in the THINRS Study |
| Thornber K |
- |
Comparison of the Role of Protein Kinase C (PKC) in Platelet Spreading on Fibrinogen and Collagen Related Peptide (CRP) |
| Thummala A |
- |
Reduced Bleeding Achieved through the Encapsulation of a Clot-busting Drug |
| Thumpston J |
- |
Clinical and Laboratory Diagnosis of Heparin Induced Thrombocytopenia (HIT) |
| Thys C |
- |
Loss of Gs Activity in Platelets from Carriers with a Heterozygous Missense Mutation in the Regulator of G-protein Signaling 2 (RGS2) |
| |
- |
The b1-Tubulin Q43p Functional Polymorphism Reduces the Risk of Cardiovascular Disease by Modulating Platelet Function and Structure |
| Tian J |
- |
Alanine Mutagenesis Demonstrates Functional Importance of Four Amino Acids Within the Disintegrin Eristostatin: Implications for Its Anti-Platelet and Anti-Cancer Properties |
| Tiede A |
- |
Therapeutic Monitoring Using Rotation Thromboelastometry in Patients with Coagulation Factor VIII Inhibitors |
| |
- |
Rotation Thromboelastometry in Patients Receiving Platelet Transfusion after Chemotherapy |
| Tillmanns H |
- |
The Factor VII Activating Protease (FSAP) Is an Inhibitor of Neointimal Lesion Formation. Comparison with the Marburg I SNP (G511E) of FSAP |
| Tillyer ML |
- |
GPVI Deficiency Associated with Unexpected Severe Bleeding in a 33 year Old Patient with Moderate Thrombocytopenia and Autoantibodies Against the Ig-like Domains |
| Tilman MH |
- |
Protein S Multimers are Generated in vitro and do Not Bind to C4b-binding Protein: Implications for Protein S Structure-Function Analysis |
| Timmerman JJ |
- |
Analysis of Blood Coagulation in Mice: Pre-analytical Conditions and Comparison of a Home-made Assay for Thrombin-antithrombin Complexes with Two Commercial Assays |
| Tincani A |
- |
Antiphospholipid Antibodies in 42 Neonates Born to Mothers with the Antiphospholipid Syndrome and Included in the European Forum Register |
| Ting S |
- |
Comparing Subcutaneous Low Molecular Weight Heparin (Dalteparin) Versus Intravenous Unfractionated Heparin in the Treatment of Acute Sub-massive Pulmonary Embolism: An Open Randomised Trial |
| Tinlin S |
- |
Understanding the Genotype/Phenotype Link in Type 1 von Willebrand Disease (VWD): Results from The Canadian Type 1 VWD Study |
| |
- |
The Mutational Spectrum of Type 1 Von Willebrand Disease (VWD): Results from the Canadian Type 1 VWD Study |
| Tirado I |
- |
The ABO Blood Group Genotype and Factor VIII Levels as Independent Risk Factors for Venous Thromboembolism |
| Tiraferri E |
- |
Management of the Patients on Long Term Oral Anticoagulant Treatment (OAT) Undergoing Elective Surgery: Experience of the Italian Anticoagulation Clinics |
| Tiret L |
- |
Haemostatic Factors and the Risk of Cardiovascular Death in Patients with Coronary Artery Disease: The AtheroGene Study |
| |
- |
TAFI Gene Polymorphisms and Plasma TAFI Levels: A Trans-Ethnic Association Study |
| Tiscia T |
- |
The COX-2 G/C-765 Polymorphism Modulates the Occurrence of Cerebrovascular Ischemia |
| |
- |
Successful Diagnosis in Pregnant Obligate Carriers of Hemophilia a of Fetal Sex Using Conventional Pcr Analysis of Maternal Plasma |
| Titaeva E |
- |
Homocystein and Hemostatic Variables in Young Postinfarction Patients |
| |
- |
Relation of Changes in D-dimer and Factor VIIa Levels after Treatment with Heparins to Clinical Outcomes of Unstable Angina |
| |
- |
Matrix Metalloproteinases and Markers of Thrombin Generation in Patients with Restenosis after Percutaneous Coronary Interventions |
| Titov V |
- |
Homocystein and Hemostatic Variables in Young Postinfarction Patients |
| Tizon A |
- |
Evolution of Antithrombin (AT) and Fibrinogen (Fg) Levels during Induction Chemotherapy with L-asparaginase (Asp) in Adult Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL). Clinical Outcomes and Use of Coagulation Supportive Treatments: The CAPELAL Study |
| Tjärnlund Wolf A |
- |
Fibrinolytic Gene Polymorphism and Ischemic Stroke |
| Tjønnfjord GE |
- |
A Baltic Origin of the Common ADAMTS13 Mutation 4143insA |
| Tobon LI |
- |
Thrombophilia in a Healthy Population from Northwest Colombia |
| Tobón LI |
- |
The First Homozygous Family for Factor II G20210A Mutation in Latin America |
| Tobu M |
- |
Protein Chip Array Profiles in End Stage Renal Disease (ESRD) Patients |
| |
- |
Comparative Study on the Anticoagulant Effects of Low Molecular Weight Heparins As Measured by Whole Blood ACT, Anti-Xa and a Newly Developed Prothrombinase Induced Clotting Time (PiCT) Assay |
| |
- |
Tissue Factor, Thrombomodulin and P-Selectin Levels Are Increased in End Stage Renal Disease |
| |
- |
Upregulation of Inflammatory Mediators in ESRD Patients: Pathophysiologic Implications |
| Toff WD |
- |
Hypobaric Hypoxia Reduces Thrombus Formation Rate Measured by Thromboelastography |
| |
- |
Hypobaric Hypoxia Does Not Influence Markers of Coagulation, Platelet, Endothelial or Fibrinolytic Activation |
| Toft E |
- |
Atorvastatin Treatment Affects Vitamin K-Dependent Coagulation Factors (INR) In Patients With Coronary Heart Disease |
| Togna A |
- |
D-Dimer and the Risk of Venous Thromboembolism in Medical Patients |
| Tognazzo D |
- |
CRM+ Factor V Deficiency Arg2080Cys: A Model to Investigate Altered C2 Domain-Membrane Interaction |
| Tognazzo S |
- |
Common Factor XIII Gene Polymorphisms in Venous Leg Ulcers |
| Tognin G |
- |
Soluble Endothelial Protein C Receptor (sEPCR) Levels, A3 Haplotype of EPCR Gene and the Risk of Thrombosis in Carriers of Antithrombin (AT), Protein C (PC) and Protein S (PS) Defects |
| |
- |
Long-Term Treatment with High-Dose Recombinant Human Antithrombin does not Prevent Acute Humoral Rejection in Primate Recipients of Porcine Xenografts |
| |
- |
The G20210A Prothrombin Variant (PT-G20210A) and the Risk of Thromboembolism and Foetal Loss in Pregnant Women: A Retrospective Cohort Study |
| |
- |
Soluble Endothelial Protein C Receptor Levels (sEPCR) and Thrombotic Manifestations in Carriers of Dysfunctional Protein C Variants |
| Tognin G |
- |
Clinical and Molecular Characterization of Three Italian Patients with Severe Factor V Deficiency and Bleeding Disorder (Parahaemophilia): Report of a Novel Homozygous Mutation (FV: Asp524His) |
| Tognin G |
- |
Venous Thromboembolism (VTE) in Patients with Antiphospholipid Antibodies Against Protein C and/or Protein S: A Case-Control Study |
| Toh C-H |
- |
Measurements of Soluble Thrombomodulin Activity and Antigen: Factors Contributing to Variance and Potential for Identification of Protein Variants |
| Toh C-H |
- |
Cardiovascular Risk Factors Contributing to Endogenous Thrombin Potential (ETP) in Type 2 Diabetes |
| Toh CH |
- |
In Patients with the Biphasic Waveform, Lipoprotein Complexation Does Not Retard C-Reactive Protein Induced Complement Activation |
| |
- |
Activated Protein C (APC) Bound to Microparticle-Associated Endothelial Protein C Receptor (EPCR) Occurs in vivo and Has Anticoagulant Properties |
| |
- |
Inactivation of Factor V during Sepsis-Induced Disseminated Intravascular Coagulation: Reconciliation of Total Factor V Activity with Its Cleavage and Inactivation as Assessed by SDS-PAGE and Immunoblotting |
| |
- |
The Mechanism of Alpha-1-Protease Inhibitor Inactivation During Sepsis-Induced Disseminated Intravascular Coagulation |
| Tokajuk P |
- |
Immunohistochemical Localization of Protein Z (ZP) and Protein Z-Dependent Protease Inhibitor (ZPI) in Situ in Human Malignant Tumors |
| Tokunaga Y |
- |
C-terminal Heparin-Binding Peptide of Snake Venom VEGF Specifically Blocks VEGF-stimulated Endothelial Cell Proliferation |
| Tokunaga Y |
- |
Identification of Heparin-Binding Region of Snake Venom VEGF (VEGF-F) and Its Blocking Effect on VEGF-A165 |
| Toltl L |
- |
Modulation of Monocyte Function by Activated Protein C, a Natural Anticoagulant |
| Tom B |
- |
Functional Differences in the Response of Platelets to Collagen That Are Linked to Glycoprotein VI Genotype Are Also Associated with Differences in Platelet Gene Expression Profiles |
| Tomaiuolo M |
- |
Successful Diagnosis in Pregnant Obligate Carriers of Hemophilia a of Fetal Sex Using Conventional Pcr Analysis of Maternal Plasma |
| Tomaszewski D |
- |
AT, TAT and F1+F2 in Radically Operated Non-small Cell Lung Cancer Patients |
| |
- |
Concentration of TF and TFPI in Non-Small Cell Lung Cancer |
| |
- |
Concentration of TAFI and D-Dimers in Radically Operated Non-Small Cell Lung Cancer Patients |
| |
- |
Correlation Between Selected cloTting Factors Parameters and Apoptosis of Peripheral T Lymphocytes in Non-Small Cell Lung Cancer |
| Tomaszewski R |
- |
Diving and Decompression Have Significant Effect on the Activation of Fibrinolysis |
| Tomaszewski D |
- |
Determination of Known Risk Factors of Thromboembolism in Laryngeal and Non-small Cell Lung Cancer Patients |
| |
- |
Expression of the Death Receptor Fas (CD95) on Peripheral T Lymphocytes in Correlation with Selected Clotting System Parameters in Non-Small Cell Lung Cancer |
| Tomer A |
- |
Autoimmune Thrombocytopenia: Flow Cytometric Determination of Platelet-associated Autoantibodies against Platelet Specific Receptors |
| Tomihisa K |
- |
Biological Properties of a Specific Gaq/11 Inhibitor, YM-254890, on Platelet Functions and Thrombus Formation under High-shear Stress |
| Tomilin V |
- |
The Role of Mild Forms of Coagulopathias and Pathology of Platelets in the Development of Menorrhagia and Metrorrhagia |
| |
- |
The Role of Mild Forms of Coagulopathias and Pathology of Platelets in the Development of Menorrhagia and Metrorrhagia |
| Tominec U |
- |
Warfarin and Plasma Concentrations of Some Metalloproteinases in Patients with Popliteal Arterial Aneurysm |
| Tomiyama Y |
- |
Enhanced Platelet Aggregation and Thrombogenic Tendency in Adiponectin-Deficient Mice |
| |
- |
Negative Regulation of Platelet Function by a Secreted Cell Repulsive Protein, Semaphorin 3A |
| |
- |
Generation and Characterization of ADAMTS13-Deficient Mice |
| Tomkowski W |
- |
Thromboprophylaxis with Fondaparinux in Acutely Ill Medical Patients Aged 75 years or More, or with Moderate Renal Impairment |
| |
- |
Benefit of Fondaparinux in Medical Patients: A Subgroup Analysis |
| Tomoike H |
- |
Identification of Genetic Variations in Genes Comprised in Vitamin K-dependent g-Carboxylation System |
| Tomokiyo K |
- |
Rational of Pharmacological Effect of a Combination of FVIIa and FX for Hemophilia with Inhibitors |
| Tonello S |
- |
Cerebral Venous Thrombosis: The Padua Experience |
| Toni D |
- |
The COX-2 G/C-765 Polymorphism Modulates the Occurrence of Cerebrovascular Ischemia |
| |
- |
Successful Diagnosis in Pregnant Obligate Carriers of Hemophilia a of Fetal Sex Using Conventional Pcr Analysis of Maternal Plasma |
| Tõnismägi K |
- |
Snake Venom Apoptotic L-Amino Acid Oxidase (LAAO) Inhibits Platelet Aggregation |
| Tonn T |
- |
Epitope Mapping of the Factor VIII-specific T Cell Response in E-17 Knockout Mice Using Peptide Pool Arrays |
| Tonn T |
- |
Both, COP I and COP II Coatomers Are Involved in the Anterograde ER to Golgi Transport of B-domain Deleted FVIII |
| Tonnu L |
- |
Phospholipids (PL) Induce a Conformational Change Required for Protein Z-Dependent Protease Inhibitor (ZPI) Inhibition of Factor Xa But Not Factor IXa |
| Topal G |
- |
The Thrombin-Thrombomodulin Complex Activates Nitric Oxide Synthase 3 through Calmodulin Kinase II and Phosphoinositide 3-kinase Signalling |
| Topf HG |
- |
Living with Morbus Glanzmann A Case Report of a Now 20 Year Old Mother |
| Topf HG |
- |
High Titre Inhibitor in a Paediatric Haemophilia B Patient |
| Topic Zrinski R |
- |
Ischemic Childhood Stroke and Lipoprotein (a) |
| Torchet MF |
- |
WILFACTIN: Efficacy and Safety Evaluation of WILFACTIN (a Triple Secured Von Willebrand Factor Product with a Low Factor VIII Content) in Women with Severe Von Willebrand Disease during Gynaecological/Obstetrical Events |
| |
- |
Pharmacokinetic Study of the Co-administration of a Von Willebrand Factor (VWF) Product Containing Low FVIII Level (WILFACTIN) with a Factor VIII Product |
| Torchet M-F |
- |
Factor X Gene Mutations Affecting the Gla Domain of the Protein |
| Torelli F |
- |
Central Venous Catheters Related Thrombosis in Hematological Patients |
| Tormene D |
- |
Venous Thromboembolism and the Risk of Subsequent Symptomatic Atherosclerosis |
| |
- |
Risk of Recurrent Venous Thromboembolism Associated with Inherited Deficiency of Natural Anticoagulants |
| |
- |
Venous Thromboembolism (VTE) in Patients with Antiphospholipid Antibodies Against Protein C and/or Protein S: A Case-Control Study |
| |
- |
Is There a Role of Thrombophilia in the Progression of Carotid Plaques and/or in the Onset of Cerebrovascular Ischemic Events in Asymptomatic Patients? Results of a Prospective Study (CAST Study) |
| |
- |
Soluble Endothelial Protein C Receptor (sEPCR) Levels, A3 Haplotype of EPCR Gene and the Risk of Thrombosis in Carriers of Antithrombin (AT), Protein C (PC) and Protein S (PS) Defects |
| |
- |
A Common Pathogenetic Link between Venous Thrombosis and Atherosclerosis: Increased Prevalence of Small, Dense LDL |
| Tormene D |
- |
The G20210A Prothrombin Variant (PT-G20210A) and the Risk of Thromboembolism and Foetal Loss in Pregnant Women: A Retrospective Cohort Study |
| Tormene D |
- |
Thrombin Generation and Activated Protein C Resistance in Factor V Leiden Pseudo-homozygous Patients |
| |
- |
Soluble Endothelial Protein C Receptor Levels (sEPCR) and Thrombotic Manifestations in Carriers of Dysfunctional Protein C Variants |
| |
- |
Increased Risk of Recurrent Venous Thromboembolism in Patients with Deep-Vein Thrombosis Who Are Carriers of the Factor V Leiden or Prothrombin Gene Mutation. A Meta-Analysis |
| Tornehave D |
- |
The Effect of rFVIIa on Thrombin Generation, Whole Blood Clot Formation, and Resistance to Fibrinolysis under Conditions Mimicking Hemophilia A |
| |
- |
Recombinant FVIIa Acts in a Tissue Factor Independent Way in a Mouse Model of Hemophilia A |
| Tornvall P |
- |
Contrast Medium Attenuates Platelet Activation and Platelet-Leukocyte Cross-Talk |
| Torres S |
- |
Monitoring Different Hemostasis Reactions (Chronometric, Chromogenic and Immunoturbidimetric), Using CCD Technology Based Sensor |
| Torres JD |
- |
The First Homozygous Family for Factor II G20210A Mutation in Latin America |
| |
- |
Thrombophilia in a Healthy Population from Northwest Colombia |
| TorresDra Paz OA |
- |
Use of Recombinant VIIa Factor in the Treatment of Bleed in Central Nervous System of Haemophilic Patients with Inhibitor Against Factor VIII |
| Torsten K |
- |
Selective Thrombosis of Tumor Vasculature by RGD-directed Delivery of Truncated Tissue Factor (tTF) |
| Torti M |
- |
Study of the Role of Membrane Lipid Rafts in Estrogen Signaling in Human Platelets |
| |
- |
Both Haploinsufficiency and Dominant Negative Effect Are Responsible for Hematological Abnormalities of Patients with  -Related Disease |
| Tosetto A |
- |
Abnormal Multimeric Pattern Is Not Associated with Increased Bleeding Symptoms in Index Cases of Families with Type 1 VWD. Results from the EU MCMDM-1 VWD Study |
| |
- |
Hereditary Protein C Deficiency: Prevalence and Risk of Venous Thromboembolism in the General Population. Preliminary Results from the Vita Study |
| |
- |
The D-dimer (DD) Test to Establish the Duration of Anticoagulation after a First Unprovoked Episode of Venous Thromboembolism (VTE); the Prospective Randomized Prolong Study on behalf of the Italian Federation of Anticoagulation Clinics (FCSA) |
| |
- |
Eight Novel Mutations in FXI Gene |
| |
- |
The Factor VIII/von Willebrand Factor Antigen (FVIII/VWF : Ag) Ratio in Determining VWF Defects in Patients with von Willebrand Disease Type 1: Results from the European Multicenter MCMDM-1VWD Study |
| |
- |
Management of the Patients on Long Term Oral Anticoagulant Treatment (OAT) Undergoing Elective Surgery: Experience of the Italian Anticoagulation Clinics |
| |
- |
Association of FVIII/Von Willebrand Factor Measurements and PFA-100® with Bleeding Score in Type 1 Von Willebrand Disease (VWD) Families. The MCMDM-1 Study |
| Tosetto A |
- |
Analysis of Bleeding Score in Type 1 VWD Families in the MCMDM-1 Study |
| Tosetto A |
- |
Collagen Binding (VWF : CB) Is Less Sensitive Than Ristocetin Cofactor Activity (VWF : RCo) in Suggesting Von Willebrand Factor (VWF) Molecular Defects in Patients with Von Willebrand Disease Type 1: Results From the European Multicenter MCMDM-1VWD Study |
| Toshihiko K |
- |
Diagnosis of Deep Vein Thrombosis by Soluble Fibrin or D-dimer |
| Toshihiro O |
- |
Diabetic Microangiopathy is a Disease of Disturbance of the PDGF-BB/PKC Axis, But Not of Impaired Expression of Angiogenic Factors |
| Toshio U |
- |
Biological Properties of a Specific Gaq/11 Inhibitor, YM-254890, on Platelet Functions and Thrombus Formation under High-shear Stress |
| Toso R |
- |
Removal of Hirudin-Like Sequences within the Factor Va Heavy Chain Does Not Impair Prothrombinase Function |
| Tóth J |
- |
Comparison of Platelet Deposition on Collagen in Cone-And-Plate and Parallel Plate Flow Chambers |
| Toth-Zsamboki E |
- |
NF279 Inhibits the Contribution of P2X1 to Arteriolar Thrombosis Via Partial Agonism |
| Toth-Zsamboki E |
- |
Statins Do Not Interfere with the Antiplatelet Effect of Loading Dose Clopidogrel in Patients with Ischemic Heart Disease |
| Touka MA |
- |
Functional Role of Human P-Selectin (CD62P) Polymorphisms in Mediating Cell-Cell Interactions |
| Toulon PA |
- |
Analytical Performances of a New Screening Assay to Evaluated the Functionality of the Protein C Anticoagulant Pathway, and Effect of Pre-Analytical Variables on the Test Result |
| |
- |
Orientia Tsutsugamushi Infection (scrub typhus) Is Associated with an Infraclinical Activation of the Coagulation System But Not with an Activation of Endothelial Cells |
| Toulon P |
- |
HemosIL ThromboPath: A Chromogenic Assay Sensitive to Major Prothrombotic Risk Factors Affecting the Protein C Pathway |
| Toulon Pierre A |
- |
Evaluation of a Fully Automated Immuno-Turbidimetric Assay to Quantify Free Protein S (HemosIL Free Protein S) |
| Touretsky N |
- |
Dynamic Responsiveness to Aspirin in Patients Undergoing PCI |
| Townsend K |
- |
Use of the Platelet Function Analyzer (PFA-100) in Screening for Platelet Function Defects |
| Trabetti E |
- |
Polymorphisms in the Hemostatic Pathway Genes and the Risk of Myocardial infarction in Patients with Advanced Coronary Artery Disease. Results from the Verona Heart Project |
| Tracey E |
- |
Determining a Functional Association Between the Integrin LFA-1 and the Volume Regulating Protein ICln in Lymphocytes |
| Tracy RP |
- |
A Quantitative Trait Locus on Chromosome 12q14.1 Influences Plasminogen Levels in the San Antonio Heart Family Study (SAFHS) |
| Träger I |
- |
Inhibition of Thrombin Generation by Warfarin |
| |
- |
Anticoagulant Effects and Inhibition of Thrombin Generation in Patients on Ximelagatran |
| |
- |
Anticoagulant Effects of Idraparinux Compared to Fondaparinux and Dalteparin |
| Tran HAM |
- |
Comparing Subcutaneous Low Molecular Weight Heparin (Dalteparin) Versus Intravenous Unfractionated Heparin in the Treatment of Acute Sub-massive Pulmonary Embolism: An Open Randomised Trial |
| Tran T |
- |
Proteolysis of CCN1 (Cyr61) by Plasmin: Functional Implications |
| Tran VH |
- |
Novel Peroxisome Proliferator-Activated Receptor (PPAR)-a Activator Derived from Gynostemma Pentaphyllum and Its Role in Inhibiting Tissue Factor (TF) Expression and Activity |
| Tran TT |
- |
The Pharmacogenetics and Inhibitor Risk (PIR) Study: Do the Multiple Forms of Wildtype Factor (F)VIII Contribute to the Development of Anti-FVIII Antibodies in Hemophilia a Patients during Coagulation Factor Replacement Therapy? |
| Tranholm M |
- |
New Scintigraphic Method for Imaging of Gastro-intestinal Bleeding: Preliminary Results from Ex Vivo Studies in Rabbits |
| |
- |
Recombinant FVIIa Acts in a Tissue Factor Independent Way in a Mouse Model of Hemophilia A |
| Tranholm M |
- |
Effect of rFVIIa Following Experimental Hemodilution with Two Different Colloids in a Rabbit Cuticle Bleeding Model |
| Trasi S |
- |
Prevalence of type 2N von Willebrand Disease in Indian VWD patients |
| Trasi S |
- |
VWF1 Andvwf2 Alleles (Intron 40) Are Suitable Markers for Carrier Detection and Antenatal Diagnosis in VWD Families in Indian Population |
| Trassard O |
- |
Increased outside-in Signaling and Adhesive Functions under Shear Conditions of Cells Expressing the aIIbb3T562N Integrin |
| Tratar G |
- |
Ultrasonic and Magnetic Resonance Characteristics of Pulmonary Emboli Ex Vivo |
| Tregouet DA |
- |
TAFI Gene Polymorphisms and Plasma TAFI Levels: A Trans-Ethnic Association Study |
| Treguer G |
- |
Clinical Impact of Screening for Factor V Leiden First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden |
| |
- |
Risk of a First Episode of Venous Thromboembolism (VTE) in First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden |
| |
- |
Risk of a First Episode of Venous Thromboembolism (VTE) in First Degree Relatives of Patients with an Acute Episode of VTE in Association with Factor V Leiden: An Analysis According to Age of Patients |
| Tremoli E |
- |
Platelet Associated Tissue Factor Expression in Patients with Antiphospholipid Syndrome |
| |
- |
Regulation of Tissue Factor Expression in Human Platelet by Nitric Oxide |
| Trenfield S |
- |
Ex Vivo Studies of the Effect of Lupus Anticoagulant on Heparin Monitoring |
| Trentini S |
- |
Oral Surgery in Patients on Oral Anticoagulant Therapy: A Randomized Comparison of Different INR Targets |
| Treumann A |
- |
Proteomic Analysis of The Low Molecular Weight Platelet Secretome Reveals the Presence of Novel N-Terminal Thrombospondin-1 Fragments |
| Triantaphilou A |
- |
An Inquiry into Death Causes Based on Autopsy Findings |
| Tricot G |
- |
High Incidence and Transitory Nature of Acquired Resistance to Activated Protein C (aAPCR) in Patients with Multiple Myeloma |
| Trienekens PH |
- |
Safe Exclusion of Deep Vein Thrombosis (DVT) by a Normal Rapid ELISA D-Dimeer (<500 Ng/Ml) and by the Combination of a Negative Compression Ultrasonography and a D-Dimer of <1000 Ng/Ml in 1330 Consecutive Outpatients with Suspected DVT in the Primary Care Setting |
| Trifirò E |
- |
Aspirin Does Not Equally Inhibit ThromboxaneA2 Formation in Long-Term Treated Patients |
| Trifiro' E |
- |
DAG Induces Ca2+ Influx through NCKX-TRPC Interaction, Independently of PKC Activity |
| Trillot N |
- |
Hormone Therapy and Venous Thromboembolism among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens |
| |
- |
Interactions between Prothrombotic Mutations and Hormone Therapy in Relation to the Risk of Venous Thromboembolism: Impact of the Route of Estrogen Administration |
| Tripodi MF |
- |
Oxidative Modification of Low-density Lipoprotein (LDL) and OxLDL/b2GPI Complexes in Patients with Infectious Endocarditis: Possible Role in Aortic Valve Disease |
| Tripodi A |
- |
APC Resistance Caused by Prothrombin G20210A Mutation Does Not Affect the Fibrinolytic Activity of Activated Protein C |
| |
- |
Italian Experience in the Assessment of Performance of Clinical Laboratories for DNA Analyses to Detect Three Thrombophilic Mutations |
| Tripodi A |
- |
Evidence of Normal Thrombin Generation in Cirrhosis Despite Abnormal Conventional Coagulation Tests |
| Tripodi A |
- |
Usefulness of Lyophilized Calibration Plasmas for International Normalized Ratio (INR) Determination with the Bovine Combined Thromboplastin (Thrombotest). Results of a Collaborative Study |
| |
- |
HemosIL ThromboPath: A Chromogenic Assay Sensitive to Major Prothrombotic Risk Factors Affecting the Protein C Pathway |
| |
- |
The D-dimer (DD) Test to Establish the Duration of Anticoagulation after a First Unprovoked Episode of Venous Thromboembolism (VTE); the Prospective Randomized Prolong Study on behalf of the Italian Federation of Anticoagulation Clinics (FCSA) |
| Triscott M |
- |
HemosIL ThromboPath: A Chromogenic Assay Sensitive to Major Prothrombotic Risk Factors Affecting the Protein C Pathway |
| |
- |
Characterization and Performance of the HemosIL Silica Clotting Time (SCT) Test for Detection of Lupus Anticoagulants |
| |
- |
Investigation of Performance and Sample Interferences for a New Automated Protein S Functional Activity Assay (HemosIL ProS) |
| Trobisch H |
- |
High Levels of Lp(a) in Complicated Pregnancies and Women with Recurrent Fetal Loss and Successful Treatment with Dalteparin |
| |
- |
Multicenter Evaluation of a New ELISA for the Determination of Prothrombin Fragment F 1+2 |
| |
- |
A Case of Pseudotumor Cerebri in a Patient with Thrombophilia |
| |
- |
Low Heparin (Dalteparin) as a New Treatment for Ophthalmological Arterial-Venous Vessels Occlusion |
| Tronchin M |
- |
Managed Hemostasis Point-Of-Care Testing in a Large Hospital: A Three-Year Experience and the Assessment of Clotting Tests |
| Tronick-Le Roux D |
- |
Microarray Analysis on Platelet RNA of a Patient with a 22q11 Microdeletion Including the Gpibbeta Gene and Associating Digeorge Syndrome, Moderate Thrombocytopenia and Large Platelets |
| Truijers M |
- |
Short and Long-term Prevention of Venous Thromboembolism. The Dutch Surgical Practice |
| Trujillo M |
- |
Clinical Course and Management of 7 Patients with Congenital Factor XIII Deficiency. Experience of a Single Institution |
| Trummal K |
- |
Snake Venom Apoptotic L-Amino Acid Oxidase (LAAO) Inhibits Platelet Aggregation |
| TrummalTõnismägi KK |
- |
A Heterodimeric Metalloprotease from Vipera Lebetina Venom Induces Human Endothelial Cell Apoptosis |
| Trummer A |
- |
Dose-dependent Platelet Activation and Microparticle Release by Different Clinical Antithymocyte Globulins |
| Trusheim H |
- |
Extracellular Nucleic Acids Serve as Novel Cofactors for Blood Coagulation Via Contact Pathway Activation |
| Trzeciak MC |
- |
Genetic Study of 16 Women with Decreased FVIII Level and Assessment of Haemophilia a Carrier Status |
| Tsabari R |
- |
Aspirin Resistance in Acute Brain Ischemia: Association with Stroke Severity and Outcome |
| |
- |
Low rate of Responsiveness to Aspirin in Acute Brain Ischemia: Association with Stroke Severity and Clinical Outcome |
| Tsai H |
- |
Recombinant ADAMTS13 Refractory to Suppression by TTP Inhibitors |
| Tsai PC |
- |
The Antithrombotic Effect of the Fibrinogen-Binding Fragment of Staphylococcus Aureus Clumping Factor A |
| Tsai C |
- |
Effect of Alcohol on Intracellular PH in Human Umbilical Cord Blood CD34+ Stem Cells |
| Tsai IH |
- |
Complete Subunit Sequences and Glycan Structures of Factor X Activator from Russell's Viper Venom |
| Tsai W-T |
- |
Clinical and Laboratory Studies of 25 Patients with von Willebrand Disease in Taiwan |
| Tsang KS |
- |
Neuro-microenvironment and Neurotrophic Factors Support ex vivo Expansion of Megakaryocytic Progenitor Cells |
| Tsang SF |
- |
Platelet Function Monitoring by the PFA-100® in Patients Taking Non-Aspirin NSAIDs |
| Tsaousidou M |
- |
Thrombophilic Mutations: A Comparison between the Microarray Technique and the Solid Phase Oligonucleotide Ligation Assay (SPOLA) |
| Tsaousidou MK |
- |
Use Of F1+2 and TAT as Markers of Prothrombinase Activity in Hemophiliacs |
| Tsaousidou M |
- |
The Possible Protective Role of FXIII Leu34 Allele in Thromboembolic Episodes. Its Coexistence with FVL and PAI-1 (4G/5G) Mutations in Thrombophiliacs |
| Tselepis AD |
- |
Antithrombotic Effect of the Peptide YMESRADR, Corresponding to Residues 313320 of the Platelet aIIb Subunit in a Rabbit Model of Carotid Artery Thrombosis |
| Tseng H-Y |
- |
Thromboxane A2 Null Mice Exhibit Resistance to Atherosclerosis and Neointima Formation in a Carotid Artery Ligation Model |
| Tseng GH |
- |
Pleiotropic Functions of Thrombomodulin Domains |
| Tseng CP |
- |
Disabled-2 Is a Secreted Anti-adhesive Molecule During Platelet Activation and Aggregation |
| Tsevrenis V |
- |
References Values of roTEM Instrument |
| Tsikaris V |
- |
Antithrombotic Effect of the Peptide YMESRADR, Corresponding to Residues 313320 of the Platelet aIIb Subunit in a Rabbit Model of Carotid Artery Thrombosis |
| Tsironis LD |
- |
Antithrombotic Effect of the Peptide YMESRADR, Corresponding to Residues 313320 of the Platelet aIIb Subunit in a Rabbit Model of Carotid Artery Thrombosis |
| Tsougas M |
- |
An Inquiry into Death Causes Based on Autopsy Findings |
| Tsoukala C |
- |
CoaguChek S Accuracy And Reproducibility in Comparison with the BCS Analyzer: Results in an Outpatient Anticoagulation Clinic |
| Tsoukala C |
- |
The Use Of ROTEM for the Evaluation of Effectiveness of Recombinant FVIIa Administration in Patients with Uncontrollable Bleeding |
| Tsoukas DD |
- |
An Inquiry into Death Causes Based on Autopsy Findings |
| Tsuchida-Straeten N |
- |
Enhanced Blood Coagulation and Fibrinolysis in Mice Lacking Histidine-Rich Glycoprotein/HRG |
| Tsuji M |
- |
Rational of Pharmacological Effect of a Combination of FVIIa and FX for Hemophilia with Inhibitors |
| Tsujikawa A |
- |
Four Novel Missense Mutations in Factor IX Gene Were Identified as Causes of Hemophilia B |
| Tsukada M |
- |
Effects of Recombinant Antithrombin Expressed in Chinese Hamster Ovary Cells on Endotoxin- or Thromboplastin-Induced DIC in Rats and Concanavalin A-Induced Liver Injury in Mice |
| Tsukada M |
- |
Purification and Characterization of Recombinant Antithrombin Expressed in Chinese Hamster Ovary Cells |
| Tsukasa O |
- |
Fatal Hemorrhagic Disorder and Vascular Intimal Carcinomatosis in Annexin II Expressing Transitional Cell Carcinoma |
| Tsutomu N |
- |
Diagnosis of Deep Vein Thrombosis by Soluble Fibrin or D-dimer |
| Tsuyuki RT |
- |
Atorvastatin Delays Thrombus Formation and Inhibits Leukocyte-Firm Adhesion to Thrombi Following Laser-Induced Arterial Injury in the Mouse |
| Tsykin A |
- |
Expression Profiling Reveals Functionally Important Genes and Coordinately Regulated Signalling Pathway Genes During in vitro Angiogenesis |
| Tsymanovich S |
- |
Activation of Fibrinolysis System at the Main Arterial and Venous Vessels Thrombosis with the Treatment of Gene-Engineering Thrombolythic Drug Triasa |
| Tuddenham EGD |
- |
Thrombin Is Required for Inflammatory Cell Recruitment and Graft Infiltration During Acute Humoral Xenograft Rejection |
| |
- |
A Common Ancestral Glycoprotein (GP) IX Gene Mutation (Asn45Ser) Causes Bernard-Soulier Syndrome (BSS) in European Families from Northern Europe and Australia |
| |
- |
Reduced Expression of ABCA1 and A Novel Missense Mutation That Results in Altered Protein Trafficking Underlie Scott Syndrome |
| Tuddenham EG |
- |
Platelet Calcium Mobilisation by Recombinant Factor VIIa Is Partially Mediated by Tissue Factor-Dependent Thrombin Generation |
| Tuddenham EGD |
- |
Mutations in the VKORC1 Gene Cause Warfarin Resistance, Warfarin Sensitivity and Combined Deficiency of Vitamin K Dependent Coagulation Factors |
| |
- |
Bone Marrow-Derived CD34+ Cells, Modified to Express Anticoagulants on Differentiation, Promote Repair to a Pre-Injured State after Endovascular Injury |
| Tufano A |
- |
Assessing Efficacy and Safety of Recombinant Activated Factor VII in Patients with Platelet Functional Abnormalities Undergoing Surgical Procedures |
| |
- |
Any Relationship Between Inherited Thrombophilia and Bleeding Phenotype or Vascular Disease in Patients with Hemophilia and von Willebrand Disease? |
| |
- |
Recurrent Arterial Thrombosis in Patients Taking Aspirin |
| Tufano A |
- |
Cardiovascular Risk Factors and the Risk of Venous Thromboembolism |
| Tufano A |
- |
Clinical and Pharmacoeconomic Impact of Secondary Prophylaxis in Young-Adults with Severe Hemophilia A |
| |
- |
Genetic and Acquired Risk Factors in Patients with Portal and Mesenteric Venous Thrombosis |
| Tugrul A |
- |
The Relationship between Pro-Inflammatory Cytokine Levels and Fibrinolytic System in Simple Obese Patients |
| Tuley EA |
- |
Platelet-VWF Complexes Are Preferred Substrates of ADAMTS13 Under Shear Stress |
| Tull S |
- |
A Novel Cytokine Mediated Route of Promoting the Adhesion of Platelets to Endothelial Cell Monolayers |
| Tullo L |
- |
Phosphorylation of the Extracellular Domain of the F11R/JAM-1 and Its Role in Platelet Aggregation |
| Tunstead J |
- |
Expression of TFPIb in Normal Human Tissues and Inhibitory Activity on Tissue Factor-Initiated Coagulation Reactions by Recombinant TFPIb from Transfected CHO Cells and Escherichia Coli |
| Turdo K |
- |
Anti Factor VIII Inhibitor: A Single Institution Experience |
| Turecek PL |
- |
A Multi-centre Assessment of the Chromogenic Method for Factor VIII:C Estimation in Plasma-derived and Recombinant Concentrates |
| |
- |
Thrombin Generation Assay A Sensitive Tool to Follow the Pharmacokinetics of Factor VIII Replacement Therapy in Haemophilia Patients |
| |
- |
Kinetics of in vivo Activation of Protein C In Healthy Animals |
| |
- |
Applications of Thrombin Generation Assay in Characterizing FVIII Bypassing Agents |
| |
- |
TECHNOTHROMBIN® TGA a Novel Thrombin Generation Assay Suitable for the New Routine Coagulation Analyzer Ceveron® Alpha |
| Turecek PL |
- |
Stability of CEPROTIN, Human Protein C Concentrate, for Use in Continuous Infusion |
| TurecekVáradi PLK |
- |
FEIBA Mode of Action |
| Turner C |
- |
Modified Human Recombinant HPA-1a Antibodies Inhibit Platelet Binding and Monocyte Activation by Polyclonal Anti-HPA-1a Sera |
| Turner M |
- |
Vav Family Proteins Are Required for Optimal Platelet Spreading on Fibrinogen |
| Turpie AGG |
- |
Observed Rates of Clinically Apparent Venous Thromboembolism and Death Due to Pulmonary Embolism Among Unselected Hospitalized Acutely Ill Medical Patients Compared to Rates Predicted from Clinical Trials |
| |
- |
Acute Treatment of Venous Thromboembolism (VTE) with Fixed-Dose, Weight-Adjusted, Unfractionated Heparin (UFH) Given Subcutaneously (sc) without Laboratory Monitoring: Randomized Comparison with Low-Molecular-Weight-Heparin (LMWH) |
| Turpie ID |
- |
Predictors of Mid-interval Low Molecular Weight Heparin Anti-Xa Levels |
| Turpie AGG |
- |
Predictors of Mid-interval Low Molecular Weight Heparin Anti-Xa Levels |
| Turpie AGG |
- |
A Comparison of Patients with DVT in Asia and Europe/Australia: Findings from the PROVE Registry |
| Turpie AGG |
- |
Heparin Levels with Subcutaneously (sc) Low-Molecular-Weight-Heparin (LMWH) and Unfractionated Heparin (UFH): Results from a Randomized Trial |
| Turpie AGG |
- |
A Characterization of Patients with Symptomatic DVT in India |
| Turpie AGG |
- |
FLEXTRA: Early vs Delayed Initiation of Postoperative Fondaparinux Prophylaxis after Joint Replacement: A Clinical Outcome Study |
| Turpie AGG |
- |
An Oral, Direct Factor Xa Inhibitor BAY 59-7939 for Prophylaxis against Venous Thromboembolism after Total Knee Replacement: A Dose-ranging Study |
| Turpie AGG |
- |
Self-Injection of Fondaparinux (Arixtra®) in the Prophylaxis against Venous Thromboembolism after Major Orthopedic Surgery is Well Accepted, Effective, and Safe: Data from the FLEXTRA Trial |
| Turpie AG |
- |
Fondaparinux Combined with Intermittent Pneumatic Compression (IPC) Versus IPC Alone in the Prevention of VTE after Major Abdominal Surgery: Results of the APOLLO Study |
| Turpie AGG |
- |
Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients: Do Perceived Risk Factors for Bleeding Influence Physicians' Practices? Findings From the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE) |
| Turpie AG |
- |
Long-Term Outcomes after Deep-Vein Thrombosis in Asia. The AIDA-Extension Study |
| Turpie AGG |
- |
Benefit of Fondaparinux in Medical Patients: A Subgroup Analysis |
| Turpie AGG |
- |
Clinical History, Risk Factors, and Use of VTE Prophylaxis in Patients with Symptomatic DVT in China |
| Turpie AGG |
- |
Low-Molecular-Weight Heparin or Unfractionated Heparin as Bridging Therapy in Patients on Long-term Oral Anticoagulants: Results from the REGIMEN Registry |
| |
- |
Thromboprophylaxis with Fondaparinux in Acutely Ill Medical Patients Aged 75 years or More, or with Moderate Renal Impairment |
| Turpie ID |
- |
Residual Anticoagulant Activity Following Bridging Low Molecular Weight Heparin: Prevalence and Risk Factors |
| Turpie AGG |
- |
Residual Anticoagulant Activity Following Bridging Low Molecular Weight Heparin: Prevalence and Risk Factors |
| Turpie AG |
- |
High Rate of Deep-Vein Thrombosis in Asia after Major Orthopedic Surgery: An Epidemiological Study with Mandatory Bilateral Venography and Central Independent Adjudication |
| Turpie AGG |
- |
Does Body Weight Influence Physician Practices for Providing Venous Thromboembolism Prophylaxis to Acutely Ill Medical Patients? Findings from IMPROVE |
| Turpie AGG |
- |
The PROVE Registry: A Prospective Registry on Venous Thromboembolic Events |
| |
- |
Bridging Anticoagulation With Enoxaparin Is Effective and Safe in Patients with a Mechanical Heart Valve (MHV) Who Require Temporary Interruption of Vitamin K Antagonist (VKA) Therapy |
| Turpie AGG |
- |
The Benefit-to-Risk Ratio of Fondaparinux Thromboprophylaxis in Patients Undergoing Major Orthopedic Surgery Is Independent of Age |
| Turrión P |
- |
Polipectomia in a Patient with a Moderate Congenital Deficiency of Factor V |
| Turunen AJ |
- |
Generation of Activated Protein C and Phagocyte Activation Associated with Immmunosuppression Using Anti-Thymocyte Globulin for Kidney Transplantation |
| Tusa G |
- |
Assessment of the Thrombophilic Risk in Women Candidates to Hormone Replacement Therapy |
| Tushuizen ME |
- |
In Type 2 Diabetes, P-Selectin- But Not CD63 -Exposing Microparticles Are Elevated in the Postprandial State |
| |
- |
The Phospholipid Composition of Cell-derived Microparticles Changes in the Postprandial State |
| Tustas R |
- |
Platelet Activation Markers and Procoagulant Phenotype of Monocytes do Correlate with Markers of Reperfusion Injury Following Reperfusion after Orthotopic Liver Transplantation |
| Tutschek B |
- |
The G20210A Prothrombin Gene Mutation and the Plasminogen Activator Inhibitor (PAI) 5G/5G Genotype Increase the Risk of Premature Onset of Severe Preeclampsia |
| Tuttle A |
- |
The Mutational Spectrum of Type 1 Von Willebrand Disease (VWD): Results from the Canadian Type 1 VWD Study |
| Tuyaret J |
- |
VEGF-R2 and Neuropilin-1 Are Involved in VEGF-A-Induced Differenciation of Human Bone Marrow Progenitor Cells |
| Tuyaret J |
- |
Fgf-Receptor Signalling is Involved in Differentiation and Recruitment of Bone Marrow Progenitor Cells into Endothelial Progenitor Cells |
| Twaddle S |
- |
Screening for Thrombophilia in High Risk Situations: A Meta-Analysis and Cost-Effectiveness Analysis |
| Tybulewicz VLJ |
- |
Evaluation of the Roles of Rac1 and Rac2 in Lamellipodia and Aggregate Formation on Collagen Under Flow |
| Tybulewicz V |
- |
Syk Plays a Critical Role in Signalling Downstream of GPVI and Integrin aIIbb3, But Is not Required for Efficient G-Protein Mediated Platelet Activation |
| Tybulewicz VLJ |
- |
Syk Plays an Essential Role Downstream of The Platelet Rhodocytin Receptor CLEC-2 |
| Tyurin KV |
- |
General Properties of the Coagulation System and Determination of Kinetic Constants for Biochemical Reactions |